# A Study to Evaluate the Efficacy and Safety of Rosuvastatin in Hypercholesterolemia.

> **NCT01982461** · NA · UNKNOWN · sponsor: **Pin Siang Medical Biotechnology Co., Ltd.** · enrollment: 40 (estimated)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **DRUG:** Rosuvastatin
- **DRUG:** Crestor®

## Key facts

- **NCT ID:** NCT01982461
- **Lead sponsor:** Pin Siang Medical Biotechnology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-11
- **Primary completion:** 2014-01
- **Final completion:** —
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2013-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01982461

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01982461, "A Study to Evaluate the Efficacy and Safety of Rosuvastatin in Hypercholesterolemia.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01982461. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*